Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Aspirin vs Enoxaparin for Prevention of Deep Venous Thrombosis in Ankle Sprain with Short-Leg Plaster Immobilization
IRCT20120726010405N5Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of aspirin and enoxaparin in deep vein thrombosis (DVT) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Incidence of deep venous thrombosis. Started May 2017; status: completed.
02
Drugs
aspirinenoxaparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on IRCT20120726010405N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120726010405N5.